These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 34995800)

  • 1. METTL3-mediated m
    Jiang L; Liu X; Hu X; Gao L; Zeng H; Wang X; Huang Y; Zhu W; Wang J; Wen J; Meng X; Wu Y
    Mol Ther; 2022 Apr; 30(4):1721-1740. PubMed ID: 34995800
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Liu X; Jiang L; Zeng H; Gao L; Guo S; Chen C; Liu X; Zhang M; Ma L; Li Y; Qi X; Wu Y
    Autophagy; 2024 May; 20(5):1072-1097. PubMed ID: 38050963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Podocyte RNF166 deficiency alleviates diabetic nephropathy by mitigating mitochondria impairment and apoptosis via regulation of CYLD signal.
    Hongbo M; Yanjiao D; Shuo W; Kun S; Yanjie L; Mengmeng L
    Biochem Biophys Res Commun; 2021 Mar; 545():46-53. PubMed ID: 33545631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. METTL3 enhances NSD2 mRNA stability to reduce renal impairment and interstitial fibrosis in mice with diabetic nephropathy.
    Tang W; Zhao Y; Zhang H; Peng Y; Rui Z
    BMC Nephrol; 2022 Mar; 23(1):124. PubMed ID: 35354439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and pharmacological inhibition of METTL3 alleviates renal fibrosis by reducing EVL m6A modification through an IGF2BP2-dependent mechanism.
    Ni WJ; Zhou H; Lu H; Ma NN; Hou BB; Li W; Kong FX; Yu JT; Hou R; Jin J; Wen JG; Zhang T; Meng XM
    Clin Transl Med; 2023 Aug; 13(8):e1359. PubMed ID: 37537731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.
    You H; Gao T; Raup-Konsavage WM; Cooper TK; Bronson SK; Reeves WB; Awad AS
    Kidney Int; 2017 Mar; 91(3):671-682. PubMed ID: 27914709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPR43 deficiency protects against podocyte insulin resistance in diabetic nephropathy through the restoration of AMPKα activity.
    Lu J; Chen PP; Zhang JX; Li XQ; Wang GH; Yuan BY; Huang SJ; Liu XQ; Jiang TT; Wang MY; Liu WT; Ruan XZ; Liu BC; Ma KL
    Theranostics; 2021; 11(10):4728-4742. PubMed ID: 33754024
    [No Abstract]   [Full Text] [Related]  

  • 8. METTL14 aggravates podocyte injury and glomerulopathy progression through N
    Lu Z; Liu H; Song N; Liang Y; Zhu J; Chen J; Ning Y; Hu J; Fang Y; Teng J; Zou J; Dai Y; Ding X
    Cell Death Dis; 2021 Sep; 12(10):881. PubMed ID: 34580283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of the tunneling nanotube-TNFAIP2/M-sec system on podocyte autophagy in diabetic nephropathy.
    Barutta F; Bellini S; Kimura S; Hase K; Corbetta B; Corbelli A; Fiordaliso F; Bruno S; Biancone L; Barreca A; Papotti MG; Hirsh E; Martini M; Gambino R; Durazzo M; Ohno H; Gruden G
    Autophagy; 2023 Feb; 19(2):505-524. PubMed ID: 35659195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAD2B promotes podocyte injury through regulating Numb-dependent Notch 1 pathway in diabetic nephropathy.
    Li MR; Lei CT; Tang H; Yin XJ; Hao Z; Qiu Y; Xie YR; Zeng JY; Su H; Zhang C
    Int J Biol Sci; 2022; 18(5):1896-1911. PubMed ID: 35342338
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of
    Wang JN; Wang F; Ke J; Li Z; Xu CH; Yang Q; Chen X; He XY; He Y; Suo XG; Li C; Yu JT; Jiang L; Ni WJ; Jin J; Liu MM; Shao W; Yang C; Gong Q; Chen HY; Li J; Wu YG; Meng XM
    Sci Transl Med; 2022 Apr; 14(640):eabk2709. PubMed ID: 35417191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profile of Podocyte Translatome During Development of Type 2 and Type 1 Diabetic Nephropathy Using Podocyte-Specific TRAP mRNA RNA-seq.
    Wang Y; Niu A; Pan Y; Cao S; Terker AS; Wang S; Fan X; Toth CL; Ramirez Solano MA; Michell DL; Contreras D; Allen RM; Zhu W; Sheng Q; Fogo AB; Vickers KC; Zhang MZ; Harris RC
    Diabetes; 2021 Oct; 70(10):2377-2390. PubMed ID: 34233930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. METTL14 promotes glomerular endothelial cell injury and diabetic nephropathy via m6A modification of α-klotho.
    Li M; Deng L; Xu G
    Mol Med; 2021 Sep; 27(1):106. PubMed ID: 34503454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein S Protects against Podocyte Injury in Diabetic Nephropathy.
    Zhong F; Chen H; Xie Y; Azeloglu EU; Wei C; Zhang W; Li Z; Chuang PY; Jim B; Li H; Elmastour F; Riyad JM; Weber T; Chen H; Wang Y; Zhang A; Jia W; Lee K; He JC
    J Am Soc Nephrol; 2018 May; 29(5):1397-1410. PubMed ID: 29511111
    [No Abstract]   [Full Text] [Related]  

  • 15. Silencing of METTL3 prevents the proliferation, migration, epithelial-mesenchymal transition, and renal fibrosis of high glucose-induced HK2 cells by mediating WISP1 in m6A-dependent manner.
    Chen Y; Li P; Lin M; Jiang Y; Tan G; Huang L; Song D
    Aging (Albany NY); 2024 Jan; 16(2):1237-1248. PubMed ID: 38289593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-κB/TNF-α pathway.
    Yang H; Xie T; Li D; Du X; Wang T; Li C; Song X; Xu L; Yi F; Liang X; Gao L; Yang X; Ma C
    Mol Metab; 2019 May; 23():24-36. PubMed ID: 30862474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of podocyte-secreted angiopoietin-like-4 in diabetic nephropathy.
    Ma J; Chen X; Li JS; Peng L; Wei SY; Zhao SL; Li T; Zhu D; He YX; Wei QJ; Li B
    Endocrine; 2015 Jun; 49(2):373-84. PubMed ID: 25424436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. METTL3/YTHDF2 m6A axis mediates the progression of diabetic nephropathy through epigenetically suppressing PINK1 and mitophagy.
    Wang F; Bai J; Zhang X; Wang D; Zhang X; Xue J; Chen H; Wang S; Chi B; Li J; Ma X
    J Diabetes Investig; 2024 Mar; 15(3):288-299. PubMed ID: 38013600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel role of TRPC6 in vitamin D ameliorating podocyte injury in STZ-induced diabetic rats.
    Zhang X; Song Z; Guo Y; Zhou M
    Mol Cell Biochem; 2015 Jan; 399(1-2):155-65. PubMed ID: 25292315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
    He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
    Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.